Artículos relacionados a Novartis Foundation Symposium 229: Integrating New...
Novartis Foundation Symposium 229: Integrating New Technologies with Drug Development (Novartis Foundation Symposia) - Tapa dura
Sinopsis
This important and exciting work brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known for several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one.
This major book covers such subjects as the current state of the art in squencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomics from the point of view of the pharmaceutical industry.
"Sinopsis" puede pertenecer a otra edición de este libro.
Acerca del autor
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.
De la contraportada
Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known to several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one.
This exciting book brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. The subjects covered include the current state of the art in sequencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomes from the point of view of the pharmaceutical industry.
"Sobre este título" puede pertenecer a otra edición de este libro.
EUR 17,08
EUR 14,87 gastos de envío desde Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envíoComprar nuevo
Ver este artículo
EUR 106,50
GRATIS gastos de envío en Estados Unidos de America
Destinos, gastos y plazos de envío
Resultados de la búsqueda para Novartis Foundation Symposium 229: Integrating New...
Imagen de archivo
From Genome to Therapy: Integrating New Technologies With Drug Development
Publicado por
John Wiley And Sons Ltd, 2000
ISBN 10: 0471627445
ISBN 13: 9780471627449
Antiguo o usado
Tapa dura
Librería: Anybook.com, Lincoln, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,450grams, ISBN:9780471627449. Nº de ref. del artículo: 9270342
Gastos de envío:
EUR 14,87
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 1 disponibles
Imagen de archivo
From Genome to Therapy: Integrating New Technologies With Drug Development (Volume 229)
Publicado por
John Wiley And Sons Ltd, 2000
ISBN 10: 0471627445
ISBN 13: 9780471627449
Antiguo o usado
Tapa dura
Librería: Anybook.com, Lincoln, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: Good. Volume 229. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,450grams, ISBN:9780471627449. Nº de ref. del artículo: 9882750
Gastos de envío:
EUR 14,87
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 1 disponibles
Imagen de archivo
NOVARTIS FOUNDATION SYMPOSIUM 229: INTEGRATING NEW TECHNOLOGIES WITH DRUG DEVELOPMENT (NOVARTIS FOUNDATION SYMPOSIA)
Librería: Basi6 International, Irving, TX, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Nº de ref. del artículo: ABEOCT25-94812
Cantidad disponible: 1 disponibles
Imagen de archivo
Novartis Foundation Symposium 229 - From Genome to Therapy - Integrating New Technologies with Drug Development
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: FW-9780471627449
Gastos de envío:
EUR 4,78
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 15 disponibles
Imagen del vendedor
From Genome to Therapy : Integrating New Technologies With Drug Development
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: 85525-n
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
From Genome to Therapy: Integrating New Technologies with Drug Development - No. 229
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: ABLIING23Feb2215580225344
Cantidad disponible: Más de 20 disponibles
Imagen del vendedor
From Genome to Therapy : Integrating New Technologies With Drug Development
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: 85525-n
Gastos de envío:
EUR 17,24
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
From Genome to Therapy: Integrating New Technologies with Drug Development - No. 229
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. In. Nº de ref. del artículo: ria9780471627449_new
Gastos de envío:
EUR 13,77
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
From Genome to Therapy (Hardcover)
Publicado por
John Wiley & Sons Inc, New York, 2000
ISBN 10: 0471627445
ISBN 13: 9780471627449
Nuevo
Tapa dura
Original o primera edición
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Hardcover. Condición: new. Hardcover. This important and exciting work brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known for several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one. This major book covers such subjects as the current state of the art in squencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomics from the point of view of the pharmaceutical industry. Functional genomics is the use of genetic information to design drugs. The ability to gather genetic data in the form of complete genetic sequences for certain organisms, has accelerated to astonishing speeds, reflecting the equally astonishing growth of information-gathering technologies. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9780471627449
Cantidad disponible: 1 disponibles
Imagen del vendedor
From Genome to Therapy : Integrating New Technologies With Drug Development
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 85525
Gastos de envío:
EUR 17,24
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: Más de 20 disponibles